Date | Share Price | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) |
---|
CEO | Mr. Piotr Trzonkowsk |
IPO Date | Nov. 23, 2021 |
Location | Poland |
Headquarters | Waly Piastowskie 1 lok. 1508 |
Employees | 25 |
Sector | Healthcare |
Industries |
Poltreg S.A., a biotechnology company, develops therapies for autoimmune diseases using T-regulatory cells. It engages in the research and development of therapies for the treatment of type 1 diabetes in children and in multiple sclerosis. The company is based in Gdansk, Poland.
Past 5 years
USD 12.82
USD 12.20
USD 1.79
USD 15.49
USD 3.74
StockViz Staff
February 5, 2025
Any question? Send us an email